Librium and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Librium (chlordiazepoxide hydrochloride), especially for people who are female, 60+ old, also take Paxil, and have Osteoporosis.

The phase IV clinical study analyzes which people have Visual impairment when taking Librium. It is created by eHealthMe based on reports of 2,250 people who have side effects when taking Librium from the FDA, and is updated regularly.

What is Librium?

Librium has active ingredients of chlordiazepoxide hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 2,490 Librium users. Check the latest studies of Librium.

What is Visual impairment?

Visual impairment is found to be associated with 2,259 drugs and 2,335 conditions by eHealthMe. Check the latest studies of Visual impairment.

On Jul, 16, 2026

2,250 people reported to have side effects when taking Librium.
Among them, 20 people (0.89%) have Visual impairment.

Among these 20 people:

What is the gender of people who have Visual impairment when taking Librium? *

female: 75 %
male: 25 %

What is the age of people who have Visual impairment when taking Librium? *

What are other drugs people take besides Librium? *

What are other side effects people have besides Visual impairment? *

Fall: 9 people, 45.00%
Pain: 8 people, 40.00%
Fatigue (feeling of tiredness): 7 people, 35.00%
Weight Increased: 7 people, 35.00%
Carotid Artery Occlusion (artery blockage): 6 people, 30.00%
Hearing Impaired: 6 people, 30.00%
Cough: 6 people, 30.00%
Kidney Infection: 6 people, 30.00%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 30.00%
Injection Site Haemorrhage (bleeding from injection site): 6 people, 30.00%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 7 people, 35.00%
Depression: 3 people, 15.00%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 2 people, 10.00%
Cardiac Disorder: 2 people, 10.00%
Sleep Disorder: 2 people, 10.00%
Constipation: 2 people, 10.00%
Diabetes: 2 people, 10.00%
Parkinson's Disease: 2 people, 10.00%
Bipolar Disorder (mood disorder): 1 person, 5.00%
Blood Potassium Abnormal: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Librium and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Librium:

Librium (2,490 reports)

Visual impairment treatments and more:

Visual impairment (128,338 reports)

How severe was Visual impairment and when was it recovered:

Visual impairment in Librium

Expand to all the drugs that have ingredients of chlordiazepoxide hydrochloride:

Visual impairment and drugs with ingredients of chlordiazepoxide hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Librium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Visual impairment (2,259 drugs)

Browse all the conditions that are associated with Visual impairment:

Visual impairment (2,335 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlordiazepoxide hydrochloride (the active ingredients of Librium) and Librium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.